New diabetes drug shows promise in blood sugar and weight control

NCT ID NCT06579105

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study tested an experimental drug called AZD5004 in adults with type 2 diabetes. It aimed to see if the drug could help lower long-term blood sugar levels and reduce body weight compared to a placebo. The trial involved 406 participants and was designed to check the medicine's effectiveness and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Mobile, Alabama, 36608, United States
Research Site

Sheffield, Alabama, 35660, United States
Research Site

Vestavia Hills, Alabama, 35216, United States
Research Site

Tucson, Arizona, 85710, United States
Research Site

Little Rock, Arkansas, 72205, United States
Research Site

Long Beach, California, 90815, United States
Research Site

Los Angeles, California, 90017, United States
Research Site

Newport Beach, California, 92660, United States
Research Site

Sacramento, California, 95821, United States
Research Site

Waterbury, Connecticut, 06708, United States
Research Site

Lake City, Florida, 32055, United States
Research Site

Largo, Florida, 33777, United States
Research Site

Ocoee, Florida, 34761, United States
Research Site

Orlando, Florida, 32804, United States
Research Site

Decatur, Georgia, 30030, United States
Research Site

Savannah, Georgia, 31406, United States
Research Site

Lombard, Illinois, 60148, United States
Research Site

Potomac, Maryland, 20854, United States
Research Site

Boston, Massachusetts, 02115, United States
Research Site

Roslindale, Massachusetts, 02131, United States
Research Site

Farmington Hills, Michigan, 48334, United States
Research Site

Gulfport, Mississippi, 39503, United States
Research Site

Kansas City, Missouri, 64111, United States
Research Site

Omaha, Nebraska, 68134, United States
Research Site

Las Vegas, Nevada, 89109, United States
Research Site

Albuquerque, New Mexico, 87107, United States
Research Site

Binghamton, New York, 13905, United States
Research Site

Durham, North Carolina, 27701, United States
Research Site

Greensboro, North Carolina, 27408, United States
Research Site

Rocky Mount, North Carolina, 27804, United States
Research Site

Statesville, North Carolina, 28625, United States
Research Site

Wilmington, North Carolina, 28401, United States
Research Site

Winston-Salem, North Carolina, 27103, United States
Research Site

Fargo, North Dakota, 58104, United States
Research Site

Beachwood, Ohio, 44122, United States
Research Site

Cincinnati, Ohio, 45219, United States
Research Site

Medford, Oregon, 97504, United States
Research Site

West Chester, Pennsylvania, 19380, United States
Research Site

Gaffney, South Carolina, 29340, United States
Research Site

Bristol, Tennessee, 37620, United States
Research Site

Abilene, Texas, 79606, United States
Research Site

Dallas, Texas, 75230, United States
Research Site

El Paso, Texas, 79935, United States
Research Site

Houston, Texas, 77004, United States
Research Site

West Jordan, Utah, 84088, United States
Research Site

Charlottesville, Virginia, 22911, United States
Research Site

Manassas, Virginia, 20110, United States
Research Site

Norfolk, Virginia, 23504, United States
Research Site

Seattle, Washington, 98105, United States
Research Site

Kingwood, West Virginia, 26537, United States
Research Site

Surrey, British Columbia, V3T 2V6, Canada
Research Site

Brampton, Ontario, L6T 0G1, Canada
Research Site

Burlington, Ontario, L7M 4Y1, Canada
Research Site

Sarnia, Ontario, N7T 4X3, Canada
Research Site

Toronto, Ontario, M9V 4B4, Canada
Research Site

Lévis, Quebec, G6V 6E2, Canada
Research Site

Falkensee, 14612, Germany
Research Site

Hamburg, 22607, Germany
Research Site

Münster, 48145, Germany
Research Site

Oldenburg, 23758, Germany
Research Site

Sankt Ingbert, 66386, Germany
Research Site

Wangen, 88239, Germany
Research Site

Budapest, 1036, Hungary
Research Site

Budapest, 1083, Hungary
Research Site

Debrecen, 4032, Hungary
Research Site

Szeged, 6725, Hungary
Research Site

Chūōku, 103-0027, Japan
Research Site

Chūōku, 104-0031, Japan
Research Site

Matsuyama, 7900034, Japan
Research Site

Shinjuku-ku, 160-0008, Japan
Research Site

Bialystok, 15-435, Poland
Research Site

Krakow, 31-156, Poland
Research Site

Krakow, 31-261, Poland
Research Site

Lodz, 90-338, Poland
Research Site

Lublin, 20-718, Poland
Research Site

Poznan, 60-589, Poland
Research Site

Poznan, 61-655, Poland
Research Site

Tarnów, 33-100, Poland
Research Site

Bratislava, 831 03, Slovakia
Research Site

Prešov, 080 01, Slovakia
Research Site

Rožňava, 048 01, Slovakia
Research Site

Sabinov, 083 01, Slovakia
Research Site

Trebišov, 07501, Slovakia
Research Site

A Coruña, 15006, Spain
Research Site

Barcelona, 8035, Spain
Research Site

Madrid, 28006, Spain
Research Site

Málaga, 29010, Spain
Research Site

Seville, 41003, Spain
Research Site

Seville, 41010, Spain
Research Site

Seville, 41950, Spain
Research Site

Blackpool, FY3 7EN, United Kingdom
Research Site

Bristol, BS34 6BQ, United Kingdom
Research Site

Chesterfield, S40 4AA, United Kingdom
Research Site

Corby, NN17 2UR, United Kingdom
Research Site

Dundee, DD1 9SY, United Kingdom
Research Site

Rotherham, S65 1DA, United Kingdom
Research Site

Yate, BS37 4AX, United Kingdom

Conditions

Explore the condition pages connected to this study.

DIABETES MELLITUS, TYPE 2